FerriScan gains independent validation

Perth-based Resonance Health Ltd has gained independent international validation for its FerriScan liver treatment. The announcement was made at the American Society of Hematology conference.
FerriScan is a regulated magnetic resonance imaging liver iron test which provides high sensitivity and specificity determination of iron concentration throughout the liver.
Resonance Health managing director Dr James Williams said the independent validation of the test came from Swiss pharmaceutical company, Novartis Pharma AG, who had been using the test in clinical studies.
"Liver biopsy is the gold standard," he said. "Novartis studied several tests including FerriScan and we compared favourably to the gold standard.
"Receiving independent validation means a greater level of credibility in the medical community.
"There is now a greater awareness of FerriScan resulting in more clinics wanting to use the tests and greater sales."
The ASH conference is attended by around 20,000 delegates and is being held in Atlanta from 10th to 13th of December.
In October Resonance Health's wholly owned subsidiary, Resonance Health Analysis Services, was awarded a WA Department of Health supply contract to supply FerriScan throughout the public hospital system.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 29/03/18

1 year TSR5 year TSR
99thFamily Zone Cyber Safety107%0%
457thMejority Capital-0%-8%
490thResonance Health-7%8%
742ndRobo 3D-55%-25%
716 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

$5k Bought
$1k Bought
$13k Bought
Total value as at the date of the transaction
Source: Morningstar


117th↓Resonance Health$2.5m
123rd↓Mejority Capital$2.3m
124th↑Family Zone Cyber Safety$2.3m
126th↑Robo 3D$2.0m
236 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Resonance Health

1191stMartin Blake$60k
1346thSimon Panton$40k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer